0
Signin
countryflagUS

18889881171

MSFT 435.0 0.7061% AAPL 230.65 -1.2924% NVDA 139.965 -0.9097% GOOGL 176.965 4.2934% GOOG 178.65 4.3882% AMZN 193.73 1.5197% META 594.31 0.1736% AVGO 177.28 -1.0935% TSLA 262.2401 1.0481% TSM 195.14 -0.914% LLY 831.501 -7.977% V 291.3 3.3418% JPM 224.685 0.8008% UNH 564.77 0.4696% NVO 113.15 1.0448% WMT 81.58 -0.1469% LVMUY 134.2 -1.4033% XOM 117.0342 -0.2096% LVMHF 670.0 -1.3008% MA 513.51 1.4281%

Bionoid Pharma Inc

Healthcare US BINP

0.25USD
-(-%)

Last update at 2024-10-29T20:00:00Z

Day Range

0.250.25
LowHigh

52 Week Range

0.041.25
LowHigh

Fundamentals

  • Previous Close 0.25
  • Market Cap32.13M
  • Volume7935
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.38571M
  • Revenue TTM0.09M
  • Revenue Per Share TTM2.63
  • Gross Profit TTM 0.05M
  • Diluted EPS TTM-3.95

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2013-12-31 2012-12-31 2011-12-31 2010-12-31
Type yearly yearly yearly yearly
Date 2013-12-31 2012-12-31 2011-12-31 2010-12-31
Income before tax - - - -
Minority interest - - - -
Net income - - - -
Selling general administrative - - - -
Selling and marketing expenses - - - -
Gross profit - - - -
Reconciled depreciation - - - -
Ebit -0.38902M -0.45306M -4.79521M -3.88485M
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income - - - -
Other operating expenses - - - -
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - -
Interest income - - - -
Net interest income - - - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.00197M 0.00080M 0.00235M 0.00172M
Total revenue - - - -
Total operating expenses - - - -
Cost of revenue - - - -
Total other income expense net - - - -
Discontinued operations - - - -
Net income from continuing ops - - - -
Net income applicable to common shares -1.62295M 0.11M -3.95822M -3.90867M
Preferred stock and other adjustments - - - -
Breakdown 2013-12-31 2012-12-31 2011-12-31 2010-12-31
Type yearly yearly yearly yearly
Date 2013-12-31 2012-12-31 2011-12-31 2010-12-31
Total assets - - - -
Intangible assets - - - -
Earning assets - - - -
Other current assets - - - -
Total liab - - - -
Total stockholder equity - - - -
Deferred long term liab - - - -
Other current liab 0.02M - - -
Common stock 0.00956M 0.00528M 0.00423M 0.00367M
Capital stock - - - -
Retained earnings -20.16423M -18.54128M -18.65149M -14.66627M
Other liab - - - -
Good will - - - -
Other assets - - - -
Cash - - - -
Cash and equivalents - - - -
Total current liabilities 1.25M 1.14M 1.85M 2.20M
Current deferred revenue - - - -
Net debt - - - -
Short term debt - - - -
Short long term debt - - - -
Short long term debt total - - - -
Other stockholder equity - - -0.01683M -0.12364M
Property plant equipment 0.00345M 0.00474M 0.00626M 0.01M
Total current assets 0.09M 0.15M 0.00378M 1.03M
Long term investments - - - -
Net tangible assets -1.18655M -0.98226M -1.83935M -1.15521M
Short term investments - - - -
Net receivables 0.00752M 0.07M - -
Long term debt - - - -
Inventory 0.06M - - -
Accounts payable 0.30M 0.31M 0.40M 0.40M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total - - - -
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2013-12-31 2012-12-31 2011-12-31 2010-12-31
Type yearly yearly yearly yearly
Date 2013-12-31 2012-12-31 2011-12-31 2010-12-31
Investments - - - -
Change to liabilities 0.04M 0.13M 1.11M 0.31M
Total cashflows from investing activities -0.02420M -0.06700M -0.05137M -0.01068M
Net borrowings 0.22M 0.13M -0.01331M 0.12M
Total cash from financing activities 0.32M 0.25M -0.01331M 2.57M
Change to operating activities 0.05M 0.00206M 0.01M -0.02356M
Net income -1.62295M 0.11M -3.95822M -3.90867M
Change in cash -0.05867M 0.08M -0.98329M 0.84M
Begin period cash flow - - - -
End period cash flow - - - -
Total cash from operating activities -0.35762M -0.09382M -0.91861M -1.71802M
Issuance of capital stock - - - -
Depreciation 0.00331M 0.00152M 0.03M 0.03M
Other cashflows from investing activities - -0.06700M -0.06700M -0.06700M
Dividends paid - - - -
Change to inventory 0.01M 0.01M 0.01M 0.01M
Change to account receivables -0.00056M -0.00056M -0.00056M -0.00056M
Sale purchase of stock - - - -
Other cashflows from financing activities - -0.00502M -0.00502M -0.00502M
Change to netincome 1.17M -0.33345M 1.88M 1.87M
Capital expenditures 0.00000M 0.00000M 0.00022M 0.01M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital - - - -
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow - - - -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
BINP
Bionoid Pharma Inc		 - -% 0.25 - - 348.28 - -0.4208
ZTS
Zoetis Inc		 0.81 0.45% 182.08 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.1 0.30% 32.87 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 162.43 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.04 0.29% 13.89 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Bionoid Pharma Inc. engages in the hemp cultivation business. The company is based in Beverly Hills, California.

Bionoid Pharma Inc

433 North Camden, Beverly Hills, CA, United States, 90210

Key Executives

Name Title Year Born
Ms. Patricia Colvin Director of Operations & Financial Controller NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.